Worth knowing
A PNAS study found that a protein called fibronectin can build up in areas where myelin has been lost. This may trap immature cells that could otherwise become myelin-making cells. Blocking fibronectin improved myelin repair and symptoms in two animal models.
What this means for people with MS
This points to an interesting new biological target, but the approach has not been tested in people and there is no approved medicine based on it.
- What kind of evidence exists?
- Reviewed by independent scientists • animal models
- How reliable is this source?
- Strong for a laboratory or animal finding • original paper reviewed by independent scientists
Peer-reviewed paperRead the source ↗